News · 26 weeks80-10%
2025-12-282026-06-21
Mix4390d
- Insider26(60%)
- SEC Filings11(26%)
- Other3(7%)
- Earnings2(5%)
- Leadership1(2%)
Latest news
25 items- SECClover Health Investments Corp. filed SEC Form 8-K: Other Events8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- INSIDERCEO, Medicare Advantage Reynoso Jamie L. sold $11,281 worth of shares (2,360 units at $4.78) as part of a pre-agreed trading plan, decreasing direct ownership by 0.08% to 2,841,211 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERVP OF FINANCE AND CONTROLLER Oldakowski Joseph Frank sold $58,816 worth of shares (12,102 units at $4.86), decreasing direct ownership by 4% to 299,067 units (SEC Form 4) (for tax liability)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- SECClover Health Investments Corp. filed SEC Form 8-K: Leadership Update8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- INSIDERChief Legal Officer Soares Karen sold $21,579 worth of shares (4,681 units at $4.61), decreasing direct ownership by 0.30% to 1,567,741 units (SEC Form 4) (withholding obligation)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERCEO, Medicare Advantage Reynoso Jamie L. sold $29,274 worth of shares (6,350 units at $4.61), decreasing direct ownership by 0.22% to 2,843,571 units (SEC Form 4) to satisfy withholding obligation4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- SECClover Health Investments Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- INSIDERCEO, Medicare Advantage Reynoso Jamie L. sold $35,789 worth of shares (7,289 units at $4.91) as part of a pre-agreed trading plan, decreasing direct ownership by 0.26% to 2,849,921 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- SECClover Health Investments Corp. filed SEC Form 8-K: Other Events8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- INSIDERCEO, Counterpart Health Wai Conrad sold $879,500 worth of shares (220,426 units at $3.99) as part of a pre-agreed trading plan (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERDirector Edwards Carladenise Armbrister sold $229,687 worth of shares (67,160 units at $3.42), decreasing direct ownership by 19% to 285,432 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERInterim CFO Thornton Joseph Clay covered exercise/tax liability with 16,942 shares, decreasing direct ownership by 1% to 1,217,584 units (SEC Form 4) (withholding obligation)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- SECClover Health Investments Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- SECSEC Form 144 filed by Clover Health Investments Corp.144 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Subject)
- INSIDERCEO of Clover Care Services Priest Brady Patrick sold $345,097 worth of shares (98,039 units at $3.52), decreasing direct ownership by 5% to 2,040,222 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERChief Executive Officer Toy Andrew covered exercise/tax liability with 85,704 shares, decreasing direct ownership by 0.86% to 9,923,301 units (SEC Form 4) (withholding obligation)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- SECSEC Form 10-Q filed by Clover Health Investments Corp.10-Q - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- SECClover Health Investments Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- PRClover Health Reports First Quarter 2026 ResultsBusiness Highlights: Delivered positive GAAP Net Income in the first quarter of 2026, with strong performance across key metrics: Total revenues, Adjusted EBITDA, and Consolidated Gross ProfitMarket-leading Medicare Advantage membership growth with underlying trends tracking in line with expectationsExpect to meet or exceed full year 2026 outlook across all metrics, including achieving first full year GAAP Net Income profitability Financial Results: First quarter 2026 GAAP Net Income of $27 million, an improvement of $29 million year-over-yearFirst quarter 2026 Medicare Advantage membership of 155,773, up 51% year-over-year, and Total revenues of $749 million, up 62% year-over-yearFirst q
- SECSEC Form DEFA14A filed by Clover Health Investments Corp.DEFA14A - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- SECSEC Form DEF 14A filed by Clover Health Investments Corp.DEF 14A - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- INSIDERSEC Form 4 filed by Priest Brady Patrick4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Priest Brady Patrick4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Soares Karen4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 4 filed by Toy Andrew4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
CLOV FAQ
6 questionsWhat does Clover Health Investments Corp. do?
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.Where does CLOV stock trade?
Clover Health Investments Corp. (CLOV) is listed on NASDAQ.What sector and industry is CLOV in?
Clover Health Investments Corp. operates in the Health Care sector, Medical Specialities industry.What are analysts saying about CLOV?
Clover Health Investments Corp. has had 8 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $600.00 price target on 2024-12-17. Recent price targets range from $250.00 to $600.00.What companies are similar to CLOV?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare CLOV side-by-side with any of them on Quantisnow.How can I track CLOV on Quantisnow?
Quantisnow aggregates Clover Health Investments Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CLOV to receive live email and push alerts on every new disclosure.